Dr. Jothydev Kesavadev Featured in Malayala Manorama Arogyam

Dr. Jothydev Kesavadev was featured in the latest issue of Malayala Manorama Arogyam, where he discusses diabetes-related eye disease and emphasizes the importance of regular eye screening for the early detection and prevention of vision loss. The article aims to raise public awareness about diabetic eye complications and highlights the role of timely diagnosis and appropriate management in preserving vision.

Free Diabetes & Obesity Camp

A free diabetes awareness, screening and treatment camp was successfully conducted at Poojappura, jointly organised by the Confederation of Residents Welfare Associations (CoRWA) and the P. Kesavadev Trust. More than 300 participants received free laboratory tests and specialist medical guidance. Led by Dr. Jothydev Kesavadev and Dr. Junaid Naina, with active participation from the JDC team, the camp highlighted a high burden of elevated cholesterol and inadequately controlled diabetes, underscoring the importance of early detection, preventive care and timely treatment.

During the programme, Dr. Jothydev Kesavadev was honoured by CoRWA for his contributions to diabetes care and research. The recognition was presented by Kerala Health Minister Shri K. Muraleedharan, adding a special note of distinction to the community health initiative.

Link 1

DREAMS Diabetes Academy Conducted Free Online Q&A Session

The DREAMS Diabetes Academy conducted a free online Q&A session on 8 August 2026, providing an interactive educational platform for children and adults living with Type 1 diabetes, along with their parents and caregivers. The session focused on addressing practical questions related to diabetes management, glucose monitoring, insulin therapy, nutrition, diabetes technology, and everyday self-care.

The session featured the multidisciplinary team from Jothydev’s Diabetes Research Centre, including Dr. Jothydev Kesavadev, Dr. Arun Shankar, Dr. Asha Ashik, Ms. Geethu Sanal, and Ms. Anjana Basanth. Through expert guidance and open interaction, participants were able to clarify concerns and gain practical insights for better Type 1 diabetes management.

Through such initiatives, the DREAMS Diabetes Academy continues its commitment to providing free education, awareness, and ongoing support to people with Type 1 diabetes and their families.

Awiqli®: Redefining Basal Insulin Therapy

JPEF conducted a Mini CME on Awiqli® (insulin icodec), the once-weekly basal insulin, on 18 August 2026 at Residency Tower, Thiruvananthapuram. The session explored the science behind once-weekly basal insulin, including its mechanism of action, unique pharmacology, evidence from the ONWARDS clinical trial programme, initiation and titration, efficacy, safety, and practical clinical use.